SUMMARY: There is an urgent need to develop novel approaches to vaccination against the emerging, highly pathogenic avian influenza viruses. Here, we engineered influenza viral-like particles (Flu-VLPs) derived from retroviral core particles that mimic the properties of the viral surface of two highly pathogenic influenza viruses of either H7N1 or H5N1 antigenic subtype. We demonstrate that, upon recovery of viral RNAs from a field strain, one can easily generate expression vectors that encode the HA, NA and M2 surface proteins of either virus and prepare high-titre Flu-VLPs. We characterise these Flu-VLPs incorporating the HA, NA and M2 proteins and we show that they induce high-titre neutralising antibodies in mice
There is need for improved human influenza vaccines, particularly for older adults who are at greate...
In April 2013, human infections with a novel avian influenza (H7N9) virus emerged in China. It has c...
Background: The availability of a universal influenza vaccine able to induce broad cross-reactive im...
SUMMARY: There is an urgent need to develop novel approaches to vaccination against the emerging, hi...
BACKGROUND: Influenza A viruses are major human and animal pathogens with huge economic and societal...
Influenza A viruses are major human and animal pathogens with huge economic and societal impact from...
[[abstract]]Virus-like particle (VLP) technology is an attractive platform for the development of se...
[[abstract]]Influenza virus-like particles (VLPs) are noninfectious and the assembly of influenza VL...
Avian influenza virus remains a threat for humans, and vaccines preventing both avian and human infl...
The H1N1 influenza pandemic of 2009 stimulated interest in developing safe and effective subunit inf...
Vaccination is a cost-effective counter-measure to the threat of seasonal or pandemic outbreaks of i...
There is need for improved human influenza vaccines, particularly for older adults who are at greate...
[[abstract]]Highly pathogenic avian influenza (HPAI) clade 2.3.4.4 viruses have been reported to be ...
There is need for improved human influenza vaccines, particularly for older adults who are at greate...
In April 2013, human infections with a novel avian influenza (H7N9) virus emerged in China. It has c...
Background: The availability of a universal influenza vaccine able to induce broad cross-reactive im...
SUMMARY: There is an urgent need to develop novel approaches to vaccination against the emerging, hi...
BACKGROUND: Influenza A viruses are major human and animal pathogens with huge economic and societal...
Influenza A viruses are major human and animal pathogens with huge economic and societal impact from...
[[abstract]]Virus-like particle (VLP) technology is an attractive platform for the development of se...
[[abstract]]Influenza virus-like particles (VLPs) are noninfectious and the assembly of influenza VL...
Avian influenza virus remains a threat for humans, and vaccines preventing both avian and human infl...
The H1N1 influenza pandemic of 2009 stimulated interest in developing safe and effective subunit inf...
Vaccination is a cost-effective counter-measure to the threat of seasonal or pandemic outbreaks of i...
There is need for improved human influenza vaccines, particularly for older adults who are at greate...
[[abstract]]Highly pathogenic avian influenza (HPAI) clade 2.3.4.4 viruses have been reported to be ...
There is need for improved human influenza vaccines, particularly for older adults who are at greate...
In April 2013, human infections with a novel avian influenza (H7N9) virus emerged in China. It has c...
Background: The availability of a universal influenza vaccine able to induce broad cross-reactive im...